Nursing Review Issue 1 | Jan-Feb 2019 | Page 20

specialty focus The lure of the cure NR: You recently wrote a piece for The Monthly entitled ‘A New Theory of Cancer’, in which you said you’ve tried to go back and understand cancer from an evolutionary standpoint. What did you mean by that? Leading scientists spearhead radical rethink of cancer. Paul Davies interviewed by Conor Burke I t is time to think of cancer as a chronic disease and use cancer treatment as something that manages the disease, rather than eradicates it all together. These ideas are part of a new theory put forward by Professor Paul Davies and his colleagues, forming part of a new ‘bottom up’ approach to cancer theory. A theoretical physicist by trade, with an interest in cosmology and astrophysics, Davies’ career more closely mirrors that of the late physicist – and his friend– Stephen Hawking, than that of an oncologist. He was first approached to explore cancer research by the deputy director of the US National Cancer Institute, Dr Anna Barker, in 2008, as she sought some ‘out of the oncological box’ thinking. This led to 12 new cancer centres opening across the US, pairing physical scientists with oncologists and precipitating theories that viewed cancer through an evolutionary prism and positing new approaches to screening, as well as potentially revolutionary ideas on treatment. Nursing Review spoke with Davies to find out more about this radical rethinking of cancer. 18 | nursingreview.com.au PD: It occurred to me at the outset when I was thinking about the nature of cancer, that something that is so stubborn, so hard to treat, is unlikely to be just some sort of recent aberration. It looks like it’s deeply integrated into the nature of multicellular life as part of, if you like, the whole great life program. And evidence for this soon came to my attention. People of course dwell on human cancers, but cancers are found pretty much right across the tree of multicellular life. So all mammals, birds, insects, fish, and even plants, fungi and corals, have cancer or cancer-like phenomena. So, if you just take an evolutionary perspective and ask, “Well, when did all these species intersect into a common ancestor?”, you’re basically going back to the origin of multicellularity itself, which occurred several times independently between about 1.5 billion years ago and 600 million years ago. So, somewhere in that window, the genetic apparatus or the program that runs cancer or drives cancer got incorporated into the genomes of pretty much all of the organisms. So it’s something that comes with multicellularity. That’s not such a heretical idea, because cancer is a disease of bodies, and bodies didn’t exist before multicellularity. And when you think about the way life is done in multicellular organisms, there has to be cooperation between the individual cells in your body, what are called somatic cells, and the body as a whole. The project of a multicellular organism is to get its genes into the next generation, and those genes are conveyed through the germ line, like the sperm and eggs, but the rest of the body is a vehicle for that. But the DNA in all of your cells is all the same. It can all make a complete organism. It’s all got the plan for the whole thing. But the somatic cells have to cooperate, and they do divide, maybe 30 or 40 times, but then they reach a point where the body says that’s enough and then they commit suicide, a process called apoptosis. So the price that the somatic cells of our body pay for being part of this collective project in multicellular organisms is suicide – cell death. And cancer is a breaking of that contract between the individual cells and the body as a whole. It’s where somatic cells say, “Well, I know I’m supposed to just divide when I’m given instructions and then I’m supposed to commit suicide when the time comes, but I’m going to defy that and break out on my own and make a bid for immortality as life was two billion years ago.” So it’s a throwback to a more primitive and, in many cases, pre-multicellular type of lifeform. That’s the basic idea. When you started to break away from traditional oncology and somatic mutation theories, your problem was the ability for those theories to predict cancer. So you and your colleagues looked at the age of genes is a means of cancer prediction. Why? There’s a new science which goes by the frightening name of phylostratigraphy, and what this basically means is you can date genes. And you can compare the homologues of a particular gene across many species. So, you’ve got a gene for hair colour, but you’ll find a similar gene in other animals, and if you go further back, you’ll find that there are genes quite close to that in insects. So you can put an age on any gene, including oncogenes – the genes responsible for driving cancer. We predicted that when you look at the genes driving cancer and the genes suppressing cancer – because the body has evolved genes to do that – the tumour- suppressor genes ought to be more recently evolved, because tumours have only been a feature of life in the last billion years or so. I know this is a theoretical stage, but are there other ideas as to how these theories would be used practically in screening? Yes. At Arizona State University, my geneticist colleague Kimberly Bussey took